Top 10 Heal Care Stocks To Buy Right Now

What happened

SMART Global Holdings(NASDAQ:SGH)stock rose 43.5% in March, according to data provided byS&P Global Market Intelligence.

The stock gains correlated with SMART’s announcement that its executive chairman, Ajay Shah, would become the company’s new CEO, replacing Iain MacKenzie after a transitional period. This was followed by a strong second-quarter earnings release and a fresh round of favorable ratings coverage.

SGH data by YCharts

So what

On the heels of announcing Shah as the company’s new chief executive, the stock received a round of positive coverage from ratings firms. The company reported second-quarter earnings on March 22, delivering an 83% year-over-year revenue increase to reach $314 million in sales for the period and gross profit climbed 96% to hit $73 million. These top and bottom-line results both came in well above the average analyst estimates.

Top 10 Heal Care Stocks To Buy Right Now: Cliffs Natural Resources Inc.(CLF)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By WWW.GURUFOCUS.COM]

    For the details of Gallagher Fiduciary Advisors, LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Gallagher+Fiduciary+Advisors%2C+LLC

    These are the top 5 holdings of Gallagher Fiduciary Advisors, LLCFifth Third Bancorp (FITB) – 7,424,558 shares, 43.91% of the total portfolio. New PositionUnited States Steel Corp (X) – 3,763,643 shares, 25.82% of the total portfolio. Franklin Resources Inc (BEN) – 1,825,092 shares, 15.42% of the total portfolio. Shares reduced by 2.44%Cleveland-Cliffs Inc (CLF) – 1,780,977 shares, 2.5% of the total portfolio. Shares reduced by 1.33%Finisar Corp (FNSR) – 349,639 shares, 1.39% of t

  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

  • [By Tyler Crowe]

    At first glance, Cleveland-Cliffs’ (NYSE:CLF) most recent earnings report might make shareholders want to push the sell button as fast as they can open their brokerage accounts. But before you precipitously sour on this iron miner, take a deeper look at its results. Even though its revenue and earnings were down drastically, those declines were largely a product of its moves to shut down unprofitable assets.

Top 10 Heal Care Stocks To Buy Right Now: Quidel Corporation(QDEL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Quidel (NASDAQ:QDEL)‘s stock had its “buy” rating reiterated by Barclays in a research note issued on Thursday. They currently have a $65.00 price objective on the stock. Barclays’ price target suggests a potential upside of 8.06% from the company’s previous close.

  • [By Stephan Byrd]

    Birchview Capital LP decreased its stake in Quidel Co. (NASDAQ:QDEL) by 12.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,975 shares of the company’s stock after selling 5,000 shares during the period. Quidel makes up 1.2% of Birchview Capital LP’s portfolio, making the stock its 9th largest holding. Birchview Capital LP’s holdings in Quidel were worth $1,760,000 as of its most recent SEC filing.

Top 10 Heal Care Stocks To Buy Right Now: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Virginia Retirement Systems ET AL lifted its position in shares of National Health Investors, Inc. (NYSE:NHI) by 10.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,300 shares of the real estate investment trust’s stock after acquiring an additional 10,700 shares during the period. Virginia Retirement Systems ET AL owned approximately 0.28% of National Health Investors worth $7,826,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 Heal Care Stocks To Buy Right Now: Gevo, Inc.(GEVO)

Advisors’ Opinion:

  • [By Max Byerly]

    Amyris Biotechnologies (NASDAQ: AMRS) and Gevo (NASDAQ:GEVO) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Top 10 Heal Care Stocks To Buy Right Now: Pebblebrook Hotel Trust(PEB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Pebblebrook Hotel (PEB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news stories that may have effected Accern’s analysis:

    Get Pebblebrook Hotel alerts:

    Pebblebrook Hotel (PEB) Expected to Post Quarterly Sales of $206.07 Million (americanbankingnews.com) Keep Company Secrets Safe With a Strong Publishing Process (cmswire.com) Analysts Anticipate Pebblebrook Hotel (PEB) to Post $0.73 Earnings Per Share (americanbankingnews.com) Pebblebrook Hotel Forecasted to Earn Q2 2018 Earnings of $0.72 Per Share (PEB) (americanbankingnews.com)

    A number of brokerages recently issued reports on PEB. Boenning Scattergood restated a “hold” rating on shares of Pebblebrook Hotel in a report on Monday, April 30th. Zacks Investment Research upgraded Pebblebrook Hotel from a “hold” rating to a “strong-buy” rating and set a $40.00 target price on the stock in a report on Wednesday, May 2nd. Robert W. Baird lifted their target price on Pebblebrook Hotel from $37.00 to $38.00 and gave the stock a “hold” rating in a report on Tuesday, May 1st. Finally, ValuEngine cut Pebblebrook Hotel from a “strong-buy” rating to a “buy” rating in a report on Monday, April 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Pebblebrook Hotel presently has an average rating of “Buy” and a consensus price target of $36.61.

  • [By Matthew DiLallo]

    Improving business travel demand during the first quarter drove Pebblebrook Hotel Trust (NYSE:PEB) to update its outlook earlier this month. Those travel trends turned out to be stronger than even its more optimistic expectations, helping the company to deliver results that were above the updated forecast. Because of that, the company is even more encouraged about what lies ahead in 2018.

Top 10 Heal Care Stocks To Buy Right Now: Euro Tech Holdings Company Limited(CLWT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Lisa Levin]

    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 49 percent to $4.775 after reporting 2017 year-end results.

    Shares of Medigus Ltd. (NASDAQ: MDGS) got a boost, shooting up 34 percent to $1.5092 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.

Top 10 Heal Care Stocks To Buy Right Now: Inovio Pharmaceuticals, Inc.(INO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Inovio Pharmaceuticals (NASDAQ:INO) last posted its earnings results on Wednesday, May 9th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.22). Inovio Pharmaceuticals had a negative net margin of 292.06% and a negative return on equity of 72.04%. The company had revenue of $1.53 million during the quarter, compared to analyst estimates of $7.50 million. During the same quarter last year, the business posted ($0.31) EPS. research analysts expect that Inovio Pharmaceuticals Inc will post -1.2 EPS for the current fiscal year.

  • [By Jim Robertson]

    On Tuesday, small capInovio Pharmaceuticals (NASDAQ: INO) surged 22.63% after announcingthat its synthetic vaccine approach using a collection of synthetic DNA antigens generated broad protective antibody responses against all major deadly strains of H1 influenza viruses from the last 100 years. This includesthe virus that caused Spanish Flu in 1918. The study involvedmultiple animal models, including mice, guinea pigs and non-human primates. Given how bad flu season is this year, the announcement got plenty of attention asthe following technical chart shows:

Top 10 Heal Care Stocks To Buy Right Now: United States Cellular Corporation(USM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    U.S. Cellular (NYSE: USM) and Hutchison Telecommunications Hong Kong (OTCMKTS:HTHKY) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

  • [By Ethan Ryder]

    NII (NASDAQ: NIHD) and U.S. Cellular (NYSE:USM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

Top 10 Heal Care Stocks To Buy Right Now: Mitsubishi Heavy Industries Ltd (MHVYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Major foreign competitors today now include the French firm Areva (OTCPK:ARVCF) and the Japanese firm Mitsubishi Heavy Industry (OTCPK:MHVYF). This is not a complete list but a focus on major players.

Top 10 Heal Care Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    The delay in an FDA decision for Tegsedi puts it behind competitor Alnylam Pharmaceuticals (NASDAQ:ALNY), which expects to hear from the FDA by Aug. 11 for its hATTR drug patisiran. But Sarah Boyce, the president at Akcea Therapeutics, doesn’t think a few months will really matter: “We don’t really feel that’s going to have any impact and the drugs will be close enough together from a launch perspective. So not really [going] to make any adjustments, and we’re very well prepared to be ready to launch following approval.”

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) released first-quarter results last week, but all eyes were looking forward as the company waits for a potential approval of its hereditary TTR amyloidosis (ATTR) drug, patisiran.

  • [By Max Byerly]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.